NCT06981104View on ClinicalTrials.gov

Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

February 14, 2025

Study Completion Date

February 14, 2025

Conditions
Dry Eye Disease (DED)Asthenopia
Interventions
DRUG

0.05% cyclosporine eyedrops

0.05% cyclosporine, one drop each time, twice a day

DRUG

0.1% sodium hyaluronate eye drop

0.1% sodium hyaluronate, one drop each time, three times a day

Trial Locations (1)

Unknown

1 Xihu Avenue, Shangcheng District, Hangzhou, Zhejiang, China, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06981104 - Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT | Biotech Hunter | Biotech Hunter